The DayOne Accelerator has helped launch more than 60 innovative healthtech ventures since we started operating in 2018. You can find details of all our active alumni companies below.
Latest update: 09/09/2025
Portfolio
In the spotlight
Oncoustics
Oncoustics applies AI to raw sound signals on low-cost ultrasound devices turning these into powerful virtual biopsy tools that will democratize diagnostics.
FindMeCure / Trialhub
TrialHub: Insights that turn trials into treatments.
Theremia
Theremia is an AI-driven platform that optimizes drug development by ensuring pharmaceutical companies create the right drug for the right population subgroups.
Risklick
Revolutionizing clinical trial protocol with first-in-class AI software.
Senseera Health
Senseera’s goal is to transform precision medicine for every patient and pioneer liver diagnostics through groundbreaking chromatin epigenomics.
Portfolio
Company
Therapeutic areas
Country
Funding Stage
Development stage
FindMeCure / TrialHub
Therapeutic area: Autoimmune diseases, Oncology, Rare Disease
Country: United Kingdom
Funding Stage: Serie A
Development stage: Commercial launch
AI-powered data intelligence platform for clinical trial strategists to plan patient-centric studies.
Visit website
Autoimmune diseases, Oncology, Rare Disease
United Kingdom
Serie A
Commercial launch
Hemetron
Therapeutic area: Autoimmune diseases, Chronic diseases
Country: Switzerland
Funding Stage: Seed
Development stage: Design & development
At-home quantitative blood testing for inflammation to remotely monitor and optimize treatments.
Visit website
Autoimmune diseases, Chronic diseases
Switzerland
Seed
Design & development
Grove AI
Therapeutic area: Disease-agnostic
Country: United States
Funding Stage: Seed
Development stage: Commercial launch
AI “digital staff” that automates clinical trial recruitment, participant engagement and site workflows.
Visit website
Disease-agnostic
United States
Seed
Commercial launch
Hope Care
Therapeutic area: Cardiovascular diseases, Chronic diseases, Pulmonology
Country: Portugal
Funding Stage: Serie A
Development stage: Commercial launch
Digital health solutions for remote patient monitoring and hospital-at-home care.
Visit website
Cardiovascular diseases, Chronic diseases, Pulmonology
Portugal
Serie A
Commercial launch
IBDrelief
Therapeutic area: Bowel diseases, Chronic diseases, Gastroenterology
Country: United Kingdom
Funding Stage: Seed
Development stage: Commercial launch
Education, support and digital tools helping people live better with inflammatory bowel disease.
Visit website
Bowel diseases, Chronic diseases, Gastroenterology
United Kingdom
Seed
Commercial launch
iLoF
Therapeutic area: Chronic diseases, Neurology, Oncology
Country: United Kingdom
Funding Stage: Serie A
Development stage: Regulatory approval & launch prep
AI-powered photonics platform building a digital biomarker library for personalized drug discovery.
Visit website
Chronic diseases, Neurology, Oncology
United Kingdom
Serie A
Regulatory approval & launch prep
InSilicoTrials Technologies
Therapeutic area: Disease-agnostic, z-Other
Country: Italy
Funding Stage: Serie A
Development stage: Commercial launch
Cloud simulation platform using AI and in silico trials to accelerate safer drug development.
Visit website
Disease-agnostic, z-Other
Italy
Serie A
Commercial launch
IntellEEGent
Therapeutic area: Neurology, Pediatrics, Sleep
Country: Switzerland
Funding Stage: Pre seed
Development stage: Design & development
AI-powered pediatric EEG software detecting epilepsy and sleep markers for faster, standardized diagnostics.
Visit website
Neurology, Pediatrics, Sleep
Switzerland
Pre seed
Design & development
Lemna Bio
Therapeutic area: z-Other
Country: Switzerland
Funding Stage: Boostrapped or grants only
Development stage: Preclinical research & prototyping
Physics-inspired AI platform modeling biomolecular interactions to de-risk and accelerate drug discovery.
Visit website
z-Other
Switzerland
Boostrapped or grants only
Preclinical research & prototyping
machineMD
Therapeutic area: Neurology, Ophtalmology
Country: Switzerland
Funding Stage: Serie A
Development stage: Commercial launch
VR-based neuro-ophthalmology devices that quantitatively assess eye movements, pupils and visual fields.
Visit website
Neurology, Ophtalmology
Switzerland
Serie A
Commercial launch
